According to Zhitong Finance App, McPharmaceutical-B (02335.HK) issued an announcement. On October 15, 2026 (after the trading period), the board of directors resolved to adopt an H share incentive plan for shareholders' approval, and will seek permission from shareholders to repurchase H shares at the extraordinary shareholders' meeting held by the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.